Derycz Scientific CEO Named to 'PharmaVoice 100' for 2010
According to the profile, Mr. Derycz "started Derycz Scientific with a mission to bring published science to the masses ... While an initial online search may bring clients to the doorsteps of copyrighted materials, they still need services such as the ones offered by Derycz if they want to dig any deeper."
The profile additionally notes, "It takes a great leader to listen to good advice, draw knowledge from it, and put it into practice. It takes a truly in-touch leader to find lessons from all walks of life. Peter Derycz is just such an individual."
Commenting on the honor, Mr. Derycz stated, "Recognition by PharmaVoice of my role in the development of Derycz Scientific and its subsidiaries, like Reprints Desk, is a great way to raise our company's profile and to inform a wider circle of potential customers about our services. The attention garnered by this coverage may attract new companies to partner with us and help us advance their ability to handle a wide range of published materials."
To read the complete PharmaVoice profile of Mr. Derycz, please visit this link: http://www.pharmavoice.com/content/digital/welcome.html
Mr. Derycz's profile appears on page 76.
About Derycz Scientific®
Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.
SOURCE Derycz Scientific, Inc.